Monitoring the performance of hip implants after surgery
Official title: Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up
Run by Signature Orthopaedics · NCT06153940 · Data updated 2026-11-12
This study looks at how well certain hip implants work and how happy patients are with them after hip surgery over a couple of years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Signature Orthopaedics Industry-sponsored |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | November 22, 2023 |
| Main results expected | March 1, 2028 |
| Study ends | March 1, 2028 |
| Registry record updated | December 1, 2023 |
| Trial ID | NCT06153940 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-75 requiring unilateral primary total hip arthroplasty due to non-inflammatory degenerative joint diseases.
✕Probably not a fit
Patients with active infections, inadequate bone stock, known metal sensitivities, or those who are immuno-suppressed may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect data on the safety and performance of the Everglade Stem, World Acetabular Cup, and World Liner used in primary total hip arthroplasty. It involves a prospective follow-up of patients at various time points, including pre-operative, discharge, one year, and two years post-operative evaluations. The primary objective is to monitor the revision rate of the implants and assess patient satisfaction through the Oxford Hip Score, alongside radiographic analysis to evaluate the effectiveness of cementless fixation.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of these hip implants, potentially improving patient outcomes.
How similar studies have gone: Other studies on post-market clinical follow-up of orthopedic implants have shown success in confirming safety and performance, making this approach well-supported.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient requires unilateral primary total hip arthroplasty due to non-inflammatory degenerative joint disease (e.g. osteoarthritis, traumatic arthritis, avascular necrosis, dysplasia/DDH) * patient must be a candidate for use of the products studied, as determined jointly by the surgeon and patient * male and non-pregnant female patients aged 18-75 * patients who understand the conditions of the clinical evaluation and are willing to participate for the length of the prescribed follow-up Exclusion Criteria: * patient has active infection or sepsis(treated or untreated) enough to compromise implant stability or postoperative recovery * patient is a female of child-bearing age and not taking and not taking contraceptive pills * patient has inadequate bone stock to support the device (e.g. severe osteopenia, family history of severe osteoporosis or osteopenia) * patient has a known or suspected metal sensitivity * patient is immuno-suppressed with disease such as AIDS or is receiving high dose of cortico-steroids. * patient has an emotional or neurological condition that would pre-empt their ability or unwillingness to participate in the clinical evaluation including mental illness, mental retardation or drug abuse * patient is severely overweight with a BMI\>40.
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Nicolas Piuzzi, MD — The Cleveland Clinic
- Study coordinator: Satish A Shejale, M.S. Orthopaedics
- Email: satish.shejale@signatureortho.com.au
- Phone: +61 02 9428 5181
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Powered wearable hip exercise device to improve walking and balance in people with hip disease.
We will test whether a powered wearable hip exercise device helps people with hip osteoarthritis or femoral head osteonecrosis walk farther, faster, and with better balance.
-
PENG plus lateral femoral cutaneous nerve block versus lumbar and sacral erector spinae plane blocks for pediatric hip surgery
This trial will test whether combining a PENG block with a lateral femoral cutaneous nerve block gives better pain relief and lowers opioid use than lumbar and sacral erector spinae plane blocks in children aged 2–16 having elective hip surgery.
-
Evaluating the safety and effectiveness of pediatric orthopedic implants
This study is testing how safe and effective orthopedic implants are for kids with fractures and limb deformities to see how they perform over time.
-
ACE Acetabular Cup 10-year UK post-market follow-up
This 10-year follow-up will see how well the ACE Acetabular Cup works and how patients feel after a primary total hip replacement.
-
Collecting data on Taperloc Complete stems for hip surgeries
This study is trying to see how safe and effective the Taperloc Complete hip implants are for people who have had hip surgery, by looking at both past patients and following new ones over the years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.